Respirich 10-Montelukast sodium 10 mg tablets

Buy Respirich 10-Montelukast sodium 10 mg tablets for Bulk Order

What is Respirich 10-Montelukast sodium 10 mg tablets?

Respirich 10-Montelukast sodium 10 mg tablets are a pharmaceutical formulation of Montelukast sodium, a leukotriene receptor antagonist. It is used primarily for the management of asthma and allergic rhinitis. This compound plays a critical role in blocking substances in the body that cause allergy and inflammation.

Montelukast is classified scientifically as a sodium salt derivative, which exhibits anti-inflammatory properties. Its synthesis involves a multi-step chemical process utilizing advanced organic chemistry techniques. Regulatory-wise, Montelukast is well-documented and complies with global pharmaceutical standards, making it suitable for extensive therapeutic applications.

What Are the Applications of Respirich 10-Montelukast sodium 10 mg tablets?

• Used in the treatment of asthma for improved lung function.
• Effective in managing seasonal and perennial allergic rhinitis.
• Potential applications in research for studying leukotriene pathways.
• Formulation component in combination therapies for enhanced efficacy.

Why Choose Pharmint as Your Respirich 10-Montelukast sodium 10 mg tablets Supplier?

Pharmint offers a comprehensive global sourcing capability, ensuring high-quality Respirich 10-Montelukast sodium 10 mg tablets. Each batch comes with a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), verifying compliance with international regulations.

Benefits of partnering with Pharmint include:

• Bulk availability for large orders.
• Quick lead times for delivery.
• Export support tailored to your needs.

Storage & Handling Guidelines for Respirich 10-Montelukast sodium 10 mg tablets

Store Respirich 10-Montelukast sodium 10 mg tablets in a cool, dry place, away from direct sunlight and moisture. Ideal storage temperature is between 20°C to 25°C. Ensure that the packaging is intact to prevent air exposure, and use appropriate containers for bulk or research-grade material.

Regulatory, Documentation & Export Information

Respirich 10-Montelukast sodium 10 mg tablets is not classified as a controlled precursor. However, it may require an end-use declaration for certain applications. Available documentation includes:

• Certificate of Analysis (COA)
• Material Safety Data Sheet (MSDS)
• Drug Master File (DMF) upon request.

Respirich 10-Montelukast sodium 10 mg tablets FAQs

What is the shelf life of Respirich 10-Montelukast sodium 10 mg tablets?

The shelf life typically ranges from 24 to 36 months when stored under proper conditions. Always refer to the COA for specific details.

What are the handling precautions for Respirich 10-Montelukast sodium 10 mg tablets?

Always use protective equipment while handling. Avoid contact with skin and eyes. Follow MSDS guidelines for safety protocols.

Is Respirich 10-Montelukast sodium 10 mg tablets suitable for all patients?

Consult with healthcare professionals to determine suitability. Consider patient-specific factors such as age and medical history.

Can Respirich 10-Montelukast sodium 10 mg tablets be customized in formulations?

Yes, it can be formulated with other active ingredients for combination therapies. Consult with Pharmint for specific formulation inquiries.

How can I ensure compliance when sourcing Respirich 10-Montelukast sodium 10 mg tablets?

Partner with Pharmint for regulatory compliance support, including COA and MSDS provision, to meet your sourcing requirements.